Carregant...
Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease
PURPOSE OF REVIEW: We review the growing clinical evidence that metabolic acidosis mediates chronic kidney disease (CKD) progression and that treatment to increase the associated low serum bicarbonate (HCO(3)) in CKD is disease-modifying. RECENT FINDINGS: Seven prospective studies of patients with w...
Guardat en:
| Publicat a: | Curr Opin Nephrol Hypertens |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6467553/ https://ncbi.nlm.nih.gov/pubmed/30681417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000491 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|